A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Mohty, Razan ^{[1
]}

Junmin, Whiting ^{[2
]}

Saha, Aditi ^{[3
]}

Kim, Jongphil ^{[2
]}

Nishihori, Taiga ^{[1
]}

De Avila, Gabriel ^{[4
]}

Corallo, Salvatore ^{[1
]}

Dam, Marian ^{[1
]}

Marin, Jessica ^{[1
]}

Liu, Hien ^{[5
]}

Mokhtari, Sepideh ^{[6
]}

Jain, Michael D. ^{[1
]}

Perna, Fabiana ^{[7
]}

Blue, Brandon ^{[3
]}

Grajales-Cruz, Ariel F. ^{[4
]}

Castaneda, Omar ^{[8
]}

Shain, Kenneth ^{[4
]}

Baz, Rachid ^{[3
]}

Freeman, Ciara Louise L. ^{[8
]}

Alsina, Melissa ^{[5
]}

Locke, Frederick L. ^{[1
,5
]}

Hansen, Doris K.

Lazaryan, Aleksandr ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA

[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Indianapolis, IN USA

[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] A Novel Composite Endpoint of Toxicity-Free, Progression-Free Survival (TPFS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Saha, Aditi
Mohty, Razan
Whiting, Junmin
Flores, Kristen
Kim, Jongphil
Nishihori, Taiga
Chavez, Julio C.
Khimani, Farhad
Hansen, Doris K.
Perna, Fabiana
Liu, Hien
Shah, Bijal D.
Dam, Marian
Jaffer, Muhammad
Mokhtari, Sepideh
Elmariah, Hany
Faramand, Rawan
Bachmeier, Christina A.
Bejanyan, Nelli
Locke, Frederick L.
Jain, Michael D.
Lazaryan, Aleksandr
BLOOD, 2023, 142
[2] Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
Gagelmann, Nico
Dima, Danai
Merz, Maximilian
Hashmi, Hamza
Ahmed, Nausheen
Tovar, Natalia
Oliver-Caldes, Aina
Stoelzel, Friedrich
Rathje, Kristin
Fischer, Luise
Born, Patrick
Schaefer, Lisa
Albici, Anca-Maria
Schub, Natalie
Kfir-Erenfeld, Shlomit
Assayag, Miri
Asherie, Nathalie
Wulf, Gerald Georg
Kharboutli, Soraya
Mueller, Fabian
Shune, Leyla
Davis, James A.
Anwer, Faiz
Vucinic, Vladan
Platzbecker, Uwe
Ayuk, Francis
Kroeger, Nicolaus
Khouri, Jack
Gurnari, Carmelo
McGuirk, Joseph
Stepensky, Polina
Abdallah, Al-Ola
de Larrea, Carlos Fernandez
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (14) : 1665 - 1675
[3] Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
Salem, Dalia A.
Maric, Irina
Yuan, Constance M.
Liewehr, David J.
Venzon, David J.
Kochenderfer, James
Stetler-Stevenson, Maryalice
LEUKEMIA RESEARCH, 2018, 71 : 106 - 111
[4] BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma
Fang, Jiamin
Zhou, Fuling
ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1069 - 1083
[5] Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM)
Theprungsirikul, Poy
Yu, Mansen
Rall, Kerri
Matthews, Martin
Neparidze, Natalia
Parker, Terri L.
Browning, Sabrina
Anderson, Tara
Stevens, Erica
Foss, Francine M.
Gowda, Lohith
Pillai, Manoj
Isufi, Iris
Seropian, Stuart
Mirza, Sayeef
Bar, Noffar
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[6] Updated Results of Ciltacabtagene Autoleucel (Cilta-Cel), a B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Relapsed/Refractory Multiple Myeloma (RRMM)
Usmani, Saad Z.
Berdeja, Jesus G.
Madduri, Deepu
Jakubowiak, Andrzej
Agha, Mounzer
Cohen, Adam D.
Hari, Parameswaran
Yeh, Tzu-Min
Olyslager, Yunsi
Banerjee, Arnob
Jackson, Carolyn C.
Allred, Alicia
Zudaire, Enrique
Deraedt, William
Wu, Xiaoling
Carrasco-Alfonso, Marlene J.
Akram, Muhammad
Lin, Yi
Martin, Thomas
Jagannath, Sundar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S422 - S423
[7] Ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed/refractory multiple myeloma (R/R MM): Updated results from CARTITUDE-1.
Usmani, Saad Zafar
Berdeja, Jesus G.
Madduri, Deepu
Jakubowiak, Andrzej J.
Agha, Mounzer E.
Cohen, Adam D.
Hari, Parameswaran
Yeh, Tzu-Min
Olyslager, Yunsi
Banerjee, Arnob
Jackson, Carolyn Chang
Allred, Alicia Jones
Zudaire, Enrique
Deraedt, William
Wu, Xiaoling
Carrasco-Alfonso, Marlene
Akram, Muhammad
Lin, Yi
Martin, Thomas G.
Jagannath, Sundar
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[8] Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
Huang, He
uW, Heng-wei
Hu, Yong-xian
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (01): : 29 - 41
[9] Clinical activity of P-BCMA-ALLO1, a B-cell maturation antigen (BCMA) targeted allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed refractory multiple myeloma (RRMM) patients (pts) following progression on prior BCMA targeting therapy
Dholaria, Bhagirathbhai
Shune, Leyla
Kin, Andrew
McArthur, Katherine
Eskew, Jeff D.
Martin, Christopher E.
Haag, Sabrina
McCaigue, Joanne
Namini, Hamid
DePrimo, Sam
Cranert, Stacey
Coronella, Julia
Shedlock, Devon
Belani, Rajesh
CANCER RESEARCH, 2024, 84 (07)
[10] Subsequent anti-myeloma therapy after maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) treatment in patients with relapsed/refractory multiple myeloma
Chen, Dongjian
Wang, Xiaoxiang
Chen, Zhi
Jiang, Songfu
Jiang, Hua
Fu, Weijun
Xiang, Fang
Sun, Xuedong
Du, Juan
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E478 - E481

← 1 2 3 4 5 →